UGT1A1 and breast neoplasm: Quantitative real-time PCR was used to analyze the mRNA expression of UGT1A1, UGT1A4, UGT1A8, UGT1A10, and UGT2B7 in 57 breast tumor specimens and 35 normal (control) specimens with no evidence of malignancy (Figure 1).